Phase 2a atudy of Thykamine (PUR-0110) in patients with mild-to-moderate Atopic Dermatitis (AD)

Trial Profile

Phase 2a atudy of Thykamine (PUR-0110) in patients with mild-to-moderate Atopic Dermatitis (AD)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 09 Nov 2017

At a glance

  • Drugs Thykamine (Primary)
  • Indications Atopic dermatitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Nov 2017 Status changed from planning to recruiting according to a Devonian media release.
    • 03 Jul 2017 New trial record
    • 22 Jun 2017 According to a Devonian Health Group media release, this study is planned to start in end of june 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top